Results 1 to 10 of about 17,046 (243)
Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]
, 2017 OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M +16 more
core +20 more sources
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction [PDF]
Reviews in Cardiovascular Medicine, 2021 Heart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology.
Francesco Tona +3 more
doaj +1 more source
Cardiac Amyloidosis: from Heart Failure to Multiple Myeloma, a Case Report [PDF]
Romanian Journal of Cardiology, 2021 Cardiac amyloidosis is an underdiagnosed condition associated with a poor prognosis, likely leading to heart failure, malignant arrhythmias and death.
Mihaela HORUMBA +3 more
doaj +1 more source
Physical activity and heart failure of preserved left ventricular ejection fraction [PDF]
Fizička Kultura, 2023 Heart failure with preserved left ventricular ejection fraction (HFpEF) is a clinical syndrome in which the structure and the function of the heart are damaged, with stiffness of the heart muscle, increased pressures in diastole and in the pulmonary ...
Mikić Lidija +6 more
doaj +1 more source
Reviews in Cardiovascular Medicine, 2022 Background: The QRS fraction is the ratio of the total amplitude of R waves to the total amplitude of QRS complexes (∑R/QRS) on a 12-lead electrocardiogram.
Xiaoran Cui +6 more
doaj +1 more source
Medical Journal of Babylon, 2022 Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman +1 more
doaj +1 more source
SGLT2 Inhibition in Heart Failure with Preserved Ejection Fraction — The New Frontier
Reviews in Cardiovascular Medicine, 2023 Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome with high morbidity and increasing socio-economic burden, compounded by the lack of effective treatment options available to treat this disease.
Inês Aguiar-Neves +2 more
doaj +1 more source
Epidemiology and pathogenesis of heart failure with preserved ejection fraction [PDF]
Reviews in Cardiovascular Medicine, 2020 Heart failure (HF) is a complex syndrome that affects approximately 6.5 million adults in the United States. About half of the 6.5 million adults with HF are estimated to be individuals with heart failure with preserved ejection fraction (HFpEF). It is a
Nandini Nair
doaj +1 more source
Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
Рациональная фармакотерапия в кардиологии, 2022 Neuregulin-1β (NRG-1) is an emerging biomarker of heart failure (HF). The mechanisms of its action in HF patients are yet to be investigated. Cardioprotective and anti-inflammatory effects of NRG-1 have been reported.Aim.
K. A. Zhbanov +7 more
doaj +1 more source
Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
Рациональная фармакотерапия в кардиологии, 2021 Heart failure with preserved ejection fraction (HFpEF) is a syndrome associated with high morbidity and mortality rates. Little progress has been in the treatment of this condition since its introduction some 30 years ago.
A. A. Shchendrygina +9 more
doaj +1 more source